Genomed Spólka Akcyjna Balance Sheet Health

Financial Health criteria checks 6/6

Genomed Spólka Akcyjna has a total shareholder equity of PLN9.3M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN10.6M and PLN1.3M respectively. Genomed Spólka Akcyjna's EBIT is PLN913.4K making its interest coverage ratio 29464.2. It has cash and short-term investments of PLN2.8M.

Key information

0%

Debt to equity ratio

zł0

Debt

Interest coverage ratio29464.2x
Cashzł2.80m
Equityzł9.27m
Total liabilitieszł1.31m
Total assetszł10.58m

Recent financial health updates

No updates

Recent updates

Would Genomed Spólka Akcyjna (WSE:GEN) Be Valuable To Income Investors?

Mar 03
Would Genomed Spólka Akcyjna (WSE:GEN) Be Valuable To Income Investors?

Is Genomed Spólka Akcyjna's (WSE:GEN) Recent Performancer Underpinned By Weak Financials?

Jan 10
Is Genomed Spólka Akcyjna's (WSE:GEN) Recent Performancer Underpinned By Weak Financials?

Are Dividend Investors Getting More Than They Bargained For With Genomed Spólka Akcyjna's (WSE:GEN) Dividend?

Nov 18
Are Dividend Investors Getting More Than They Bargained For With Genomed Spólka Akcyjna's (WSE:GEN) Dividend?

Financial Position Analysis

Short Term Liabilities: GEN's short term assets (PLN6.6M) exceed its short term liabilities (PLN999.3K).

Long Term Liabilities: GEN's short term assets (PLN6.6M) exceed its long term liabilities (PLN313.4K).


Debt to Equity History and Analysis

Debt Level: GEN is debt free.

Reducing Debt: GEN had no debt 5 years ago.

Debt Coverage: GEN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: GEN has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies